Bioinformatics Advance Access published online on August 9, 2005
Bioinformatics, doi:10.1093/bioinformatics/bti612
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Computation Directorate, Lawrence Livermore National Laboratory, Livermore CA
* To whom correspondence should be addressed.
Motivation: The DeCyder software (GE Healthcare) is the current state-of-the-art commercial product for the analysis of two-dimensional difference gel electrophoresis (2-D DIGE) experiments. Analyses complementing DeCyder are suggested by incorporating recent advances from the microarray data analysis literature. A case study on the effect of smallpox vaccination is used to compare the results obtained from DeCyder to the results obtained by applying moderated t-tests adjusted for multiple comparisons to DeCyder output data that was additionally normalized. Results: Application of the more stringent statistical tests applied to the normalized 2-D DIGE data decreased the number of potentially differentially expressed proteins from the number obtained from DeCyder, and increased the confidence in detecting differential expression in human clinical studies. Availability: The marray and limma packages used here are available from http://www.bioconductor.org/.
Received June 15, 2005
Revised July 5, 2005
Accepted August 2, 2005
Article
Statistical challenges in the analysis of two-dimensional difference gel electrophoresis experiments using DeCyderTM
2 Biosciences Directorate, Lawrence Livermore National Laboratory, Livermore CA
Imola K. Fodor, E-mail: fodor1{at}llnl.gov
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. A. Karp, P. S. McCormick, M. R. Russell, and K. S. Lilley Experimental and Statistical Considerations to Avoid False Conclusions in Proteomics Studies Using Differential In-gel Electrophoresis Mol. Cell. Proteomics, August 1, 2007; 6(8): 1354 - 1364. [Abstract] [Full Text] [PDF] |
||||
